(PharmaNewsWire.Com, September 13, 2019 ) Market Overview: Cervix is the lower part of the uterus that connects to vagina. Cervical cancer develops in the cells of the cervix. Strains of Human Papillomavirus (HPV), a sexually transmitted infection, is responsible for 90% of cervical cancers. There are more than 100 strains of HPV, out of which 13 are high-risk or cancerous. Other factors include, oral contraceptives, multiple sexual partners, smoking, and HIV infection.
Market Dynamics: The market is driven by increased prevalence of cervical cancer, proactive government initiatives, awareness among people, new advancements in targeted therapies and strong pipeline of drugs. High cost of treatment and adverse effects associated with cancer therapy, less number of targeted drugs with improved clinical profile at reduced costs and lack of awareness of cancer treatment in developing countries are going to restrain the market in the forecast period.
Market Segmentation: By Type of Cancer Squamous Cell Carcinoma Adenocarcinoma Adenosquamous Carcinoma
By Treatment Surgery Radiation Therapy Chemotherapy Targeted Therapy Immunotherapy Combined Therapy
Geographical Analysis: By Geography, the market is segmented into: North America Europe South America Asia Pacific The Middle East and Africa
Competitive Analysis: Key Players: F. Hoffmann-LA Roche AG* Merck & Co., Inc. GlaxoSmithKline PLC Allergan PLC Pfizer, Inc. Biocon Ltd. Others
About Us: DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
